Bristlecone Advisors’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$517K Sell
6,371
-6,526
-51% -$503K 0.04% 166
2025
Q2
$808K Sell
12,897
-26,817
-68% -$1.59M 0.07% 137
2025
Q1
$2.86M Buy
39,714
+10,890
+38% +$886K 0.23% 89
2024
Q4
$2.48M Buy
28,824
+4,899
+20% +$488K 0.19% 94
2024
Q3
$2.27M Buy
23,925
+3,788
+19% +$336K 0.18% 100
2024
Q2
$1.92M Buy
20,137
+4,000
+25% +$476K 0.16% 105
2024
Q1
$2.13M Buy
16,137
+8,323
+107% +$1.02M 0.19% 101
2023
Q4
$1.13M Buy
+7,814
New +$1.07M 0.11% 131

Other funds holding ALB

Bristlecone Advisors's ALB Position: Q3 2025 in Review

Bristlecone Advisors reduced its Albemarle (ALB) stake by 51% in Q3 2025, selling an estimated $503K and leaving 6,371 shares worth $517K. The position accounts for 0.04% of the portfolio, ranked #166.

Bristlecone Advisors first reported a position in ALB in Q4 2023 and has held it in 8 quarters since. The position peaked at $2.86M in Q1 2025. 766 funds tracked by Wall St. Rank hold ALB as of Q3 2025.

  • Bristlecone Advisors held 6,371 shares of Albemarle worth $517K as of Q3 2025.
  • Bristlecone Advisors sold 6,526 Albemarle shares in Q3 2025, an estimated $503K.
  • Albemarle made up 0.04% of Bristlecone Advisors's portfolio in Q3 2025, its #166 holding.
  • Bristlecone Advisors first reported a position in Albemarle in Q4 2023 and has held it in 8 quarters since.
  • Bristlecone Advisors's Albemarle position peaked at $2.86M in Q1 2025.
  • 766 funds tracked by Wall St. Rank held Albemarle as of Q3 2025.

Based on Bristlecone Advisors's 13F filing for Q3 2025, filed 24 Oct 2025.